Abstract

ADP-ribosylation factor (ARF) is a small GTP-binding protein that has been implicated in intracellular vesicular transport. ARF regulates the budding of vesicles that mediate endoplasmic reticulum to Golgi and intra-Golgi transport. It also plays an important role in maintaining the function and morphology of the Golgi apparatus. Using a permeabilized cell system derived from GH3 cells, we provide evidence that ARF-1 regulates the formation of nascent secretory vesicles from the trans-Golgi network. Both myristoylated and non-myristoylated forms of recombinant human ARF-1 enhanced secretory vesicle budding about 2-fold. A mutant lacking the first 17 N-terminal residues, as well as one that preferentially binds GDP (T31N) did not stimulate vesicle formation. In contrast, a mutant defective in GTP hydrolysis (Q71L) promoted vesicle budding. Strikingly, a peptide corresponding to the N terminus of human ARF-1 (amino acids 2-17) also stimulated vesicle budding from the trans-Golgi network, in marked contrast to its inhibitory effect on vesicular transport from the endoplasmic reticulum to Golgi. These data demonstrate that in endocrine cells, ARF-1 and in particular its N terminus play an essential role in the formation of secretory vesicles.

Highlights

  • ADP-ribosylation factor (ARF)1 is a Mr 20,000 polypeptide that is a member of the Ras superfamily of small GTP-binding proteins

  • Other in vitro studies have shown that ARF-1 is required for the binding of ␥-adaptin to isolated Golgi membranes [10, 11], suggesting that it functions in the assembly of clathrin coats at the TGN

  • Experiments in which native and mutant ARF polypeptides were overexpressed in Chinese hamster ovary and normal rat kidney cells have established a key role for ARF in ER to Golgi, intra-Golgi transport, and maintenance of Golgi morphology in vivo [12, 13]

Read more

Summary

Introduction

ADP-ribosylation factor (ARF)1 is a Mr 20,000 polypeptide that is a member of the Ras superfamily of small GTP-binding proteins. To determine if nascent secretory vesicle budding from the TGN might be ARF-1-regulated, we used recombinant human ARF-1 in our permeabilized cell system. Permeabilized GH3 cells were incubated in the absence and presence of the ARF-1 polypeptides, and nascent secretory vesicles were separated by brief centrifugation and analyzed for immunoprecipitable GH (Fig. 1).

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.